Weight Loss

Eli Lilly Struggles To Keep Pace With Mounjaro, Zepbound Demand: 'Currently Unavailable' On Amazon Pharmacy
Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those Extras
Eli Lilly Stock Navigates Weight-Loss Drug Competition With Technical Resilience
Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those Extras
Eli Lilly Stock Navigates Weight-Loss Drug Competition With Technical Resilience
EXCLUSIVE: Implantable Device Shows Promise In Weight Loss Study
Is Eli Lilly Winning The War On Weight Loss Drugs? Zepbound Overtakes Wegovy In US Prescriptions

Weight Loss Recent News

US Health Agency Reviews Novo Nordisk's Wegovy For Potential Use In Treating Heart Disease Patients With Obesity
The CMS is reviewing the FDA's action to expand use of Wegovy to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight.
Oprah Winfrey To Spotlight Weight Loss Drugs In New TV Special: Will 'Shame, Blame' Come To Drug Companies — Or Could They Get Another Lift?
Weight loss drugs could get an increased spotlight with a television special from legendary TV host Oprah Winfrey.
Novo Nordisk's Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage
Novo Nordisk's Wegovy receives FDA approval for expanded use, targeting a significant reduction in cardiovascular events and weight management.
WeightWatchers Stock Falls After Q4 Results, Oprah Winfrey Exits
Director Oprah Winfrey has decided not to stand for re-election to the WeightWatchers board of directors. She has served on the board since 2015. "I look forward to continuing to advise and collaborate with WeightWatchers and CEO Sima Sistani in elevating the conversation around recognizing obesity as a chronic condition, working to reduce stigma, and advocating for health equity," said Oprah Winfrey.
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors
Zealand Pharma's drug showed positive results in 83% of patients in Phase 2 trials for MASH, heating up the race for new obesity drugs and pushing the company's shares 30% higher.
The Skinny On Novo Nordisk: Weight-Loss Meds Make Big Pharma A Big Foe For Food Industry
Novo Nordisk's groundbreaking weight-loss treatments are causing concern in the food industry. CEOs are seeking advice from the company.
Ozempic Users Might Experience Caloric Intake Rise Post-Discontinuation: Survey
Novo Nordisk's Wegovy has been linked to greater weight loss with prolonged use, with 40% of patients still using the drug a year later. This adherence rate is three times higher than other treatments.
Eli Lilly Launches Website To Help Patients With Home Delivery Options For Weight Loss Medicines
Eli Lilly announced a new website allowing patients to get a weight loss drug prescription through a telehealth provider, with disease management resources, home delivery of medicines.
Wegovy Weight Loss Drug Cuts Heart Complication Risk, Says Trial
A clinical trial has revealed that Novo Nordisk's (NYSE: NVO) weight loss drug Wegovy significantly decreases the risk of serious heart complications.
Ozempic Supply Is Running Low: Here's Why That Can Be A Problem
Ozempic, the diabetes drug also used as a so-called "miracle" weight-loss drug, has been sweeping through America and is now in limited supply.
Weight Loss Drugs Wegovy, Ozempic Gain Traction With Millennials, High Earners: New Survey Results
A new survey reveals the consumer segments showing the greatest interest in weight loss medications such as Ozempic, Mounjaro, and Wegovy.
Are People Done Buying Chips And Soda? Stock Market Winners And Losers From Rise Of Ozempic, Weight-Loss Drugs
With health and wellness becoming increasingly popular in the United States, it’s no surprise that weight-loss drugs like Ozempic and Wegovy have gone viral on TikTok and other social platf
PepsiCo Snacking Consumers Digested The Price Hikes
Macroeconomic headwinds did not slim down the third quarter results of PepsiCo Inc (NASDAQ: PEP) who today smashed Wall Street estimates along with raising its full-year guidance for a third consecutive quarter, sending shares more than 2% up during pre-market trading.
Kim Kardashian Faces Ozempic Accusations Over Dramatic Weight Loss
'Welcome To Crappie Lake' Stars Luann De Lesseps, Sonja Morgan Refute Ozempic Use: 'Are You Trying To Give Us A Hint?'
Sharon Osbourne Reveals Unpleasant Experience With Weight Loss Drug Ozempic: 'First Week Was F***ing S**t'
Elon Musk, Mark Zuckerberg, Jeff Bezos Shine Spotlight On Body Image Issues, Ozempic Craze Intensifies
'Stop Making People Feel Bad': Plastic Surgeon Lambasts Ozempic 'Shaming'
Ozempic Alternatives: These Two Drugs Show Promise In Affordability And Effectiveness For Weight Loss
Shortage Of Elon Musk-Popularized 'Miracle' Weight-Loss Drug Puts Diabetic Patients In Peril, Regulator Warns
Despite Backlash, 'Real Housewives' Star Dolores Catania Talks About Using Ozempic: 'I'm Being Realistic'
Kim Kardashian And Sharon Osbourne's Influence Leads To Ozempic-Inspired Dishes In Hollywood Restaurants
Lisa Marie Presley's Autopsy Prompts Expert To Warn About 'Miracle' Weight Loss Drug Ozempic: 'Nobody's Talking About This'